{"gene":"RXRA","run_date":"2026-06-10T07:46:28","timeline":{"discoveries":[{"year":1992,"finding":"9-cis retinoic acid directly binds and activates RXRα, identifying it as the proximate endogenous ligand for this receptor via a nuclear receptor-dependent ligand trapping assay.","method":"Nuclear receptor-dependent ligand trapping assay, direct binding measurement","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct ligand binding demonstrated biochemically, foundational finding replicated across many subsequent studies","pmids":["1309942"],"is_preprint":false},{"year":1992,"finding":"RXRα functions as an obligatory heterodimerization partner for RAR, T3R, and VDR, co-purifying with these receptors and enabling their stable binding to DNA response elements organized as direct repeats.","method":"Extensive biochemical purification, co-purification, electrophoretic mobility shift assay (EMSA), functional transactivation assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted heterodimerization biochemically with multiple receptors, replicated widely","pmids":["1314167"],"is_preprint":false},{"year":1994,"finding":"Targeted loss-of-function mutation of RXRα in mice causes embryonic lethality with hypoplastic ventricular chamber development, establishing RXRα as a genetic component of the vitamin A signaling pathway in cardiac morphogenesis.","method":"Gene targeting (knockout mouse), histological and morphological analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined developmental phenotype, replicated and extended in subsequent studies","pmids":["7926783"],"is_preprint":false},{"year":1992,"finding":"RXRα binds to a retinoic acid response element within the hepatitis B virus enhancer in vitro, and transactivates an HBV enhancer-reporter construct in vivo upon retinoic acid treatment when co-transfected with RXRα; a single-base mutation in the response element abolishes both binding and enhancer activity.","method":"In vitro binding assay, in vivo reporter gene assay, site-directed mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct binding plus mutagenesis plus functional reporter assay in single study","pmids":["1329088"],"is_preprint":false},{"year":1996,"finding":"RXRα-null mice exhibit complex cardiac defects including ventricular septal, atrioventricular cushion, and conotruncal ridge defects; RXRα heterozygous embryos show an intermediate phenotype, demonstrating a gene dosage effect for RXRα in cardiac morphogenesis.","method":"Microdissection, scanning electron microscopy, genetic analysis of RXRα-/- and +/- embryos","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO/heterozygous analysis with defined phenotype, quantitative gene-dosage effect demonstrated","pmids":["8823298"],"is_preprint":false},{"year":1998,"finding":"RXRα functions non-cell-autonomously in cardiac morphogenesis: chimera analysis shows that RXRα-deficient cardiomyocytes develop normally when surrounded by wild-type cells, indicating RXRα acts in a non-myocyte lineage to induce cardiomyocyte proliferation; RXRα and N-myc regulate convergent but non-epistatic pathways.","method":"Chimera analysis with RXRα-/- ES cells, genetic epistasis analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous chimera analysis with multiple controls establishing non-cell-autonomous mechanism","pmids":["9550727"],"is_preprint":false},{"year":2001,"finding":"Cre-mediated ablation of RXRα in epidermal keratinocytes causes progressive alopecia and epidermal hyperplasia, demonstrating that RXRα plays a key role in anagen initiation during hair follicle cycling; RXRα/VDR heterodimers are implicated as a major regulatory complex in hair cycling.","method":"Conditional knockout (Cre-loxP in keratinocytes), histological analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO with defined phenotypic readout, genetic evidence for VDR heterodimer involvement","pmids":["11171393"],"is_preprint":false},{"year":2001,"finding":"PPARγ/RXRα heterodimers are functional transcriptional units in human cytotrophoblast differentiation; specific ligands for both receptors additively stimulate human CG secretion, and RXRα and PPARγ proteins from cytotrophoblast nuclear extracts bind to the human CG β5 gene regulatory region.","method":"Transient transfection/reporter assay, nuclear extract DNA binding, hormone secretion assays, in vitro cytotrophoblast differentiation","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (binding, reporter, hormone secretion) in single study","pmids":["11564716"],"is_preprint":false},{"year":2001,"finding":"PPARγ/RXRα heterodimers inhibit human extravillous cytotrophoblast invasion in vitro; PPARγ agonists synergize with RXR agonists, and a pan-RXR antagonist reverses PPARγ agonist-induced inhibition, placing RXRα as a required partner in this pathway.","method":"Primary extravillous cytotrophoblast invasion assay, pharmacological agonist/antagonist treatment","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional invasion assay with reciprocal pharmacological manipulation, single lab","pmids":["11600579"],"is_preprint":false},{"year":2002,"finding":"Hepatocyte RXRα deficiency prevents TCPOBOP-induced hepatomegaly and abolishes induction of CYP2A5, CYP2B10, and CYP3A1 (but not CYP2E1 or CYP2D6), establishing RXRα as an essential in vivo partner for CAR- and PXR-mediated xenobiotic metabolism.","method":"Hepatocyte-specific RXRα knockout mice challenged with CAR/PXR ligands, Northern blotting, morphological analysis","journal":"European journal of pharmaceutical sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean tissue-specific KO with defined gene expression phenotype, multiple ligands tested","pmids":["11803135"],"is_preprint":false},{"year":2002,"finding":"Obstructive cholestasis reduces hepatic RAR α:RXRα nuclear protein levels and their binding to the Mrp2 promoter, with IL-1β treatment of primary hepatocytes reducing both Mrp2 and RXRα expression; renal RAR α:RXRα and Mrp2 are preserved, establishing organ-specific cytokine-dependent regulation of RXRα abundance as a mechanism for Mrp2 downregulation.","method":"Bile duct ligation model, EMSA, immunoblotting, ribonuclease protection assay, primary hepatocyte treatment","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple methods (EMSA, protein, RNA) in vivo and in vitro, organ-specific comparison","pmids":["12145812"],"is_preprint":false},{"year":2003,"finding":"Docosahexaenoic acid (DHA, an n-3 PUFA) dose-dependently activates RXRα in colonocytes using a mammalian one-hybrid assay; this activation is abolished by an RXRα antagonist but not a PPARγ antagonist, identifying DHA as a specific RXRα ligand in colonocytes.","method":"Mammalian one-hybrid assay, reporter gene assay with RXRα antagonist","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional receptor activation assay with pharmacological controls, single lab","pmids":["12844485"],"is_preprint":false},{"year":2010,"finding":"Sulindac and its analog K-80003 bind to RXRα and inhibit an N-terminally truncated form (tRXRα) that interacts with p85α subunit of PI3K; TNFα promotes tRXRα/p85α interaction to activate PI3K/AKT signaling, and sulindac inhibits this interaction leading to activation of death receptor-mediated apoptosis.","method":"Co-immunoprecipitation, drug binding assay, AKT activation assay, cell apoptosis assay, animal tumor model","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, analog with improved RXRα affinity but no COX activity, in vivo tumor model, multiple orthogonal methods","pmids":["20541701"],"is_preprint":false},{"year":2011,"finding":"Magnolol acts as a dual agonist for both RXRα and PPARγ; co-crystal structures of magnolol bound to RXRα and PPARγ LBDs reveal magnolol occupies the L-shaped ligand-binding pocket of RXRα with two hydroxyphenyl moieties in acidic and hydrophobic cavities; magnolol shows biased agonism on PPRE-mediated (RXRα:PPARγ heterodimer) transcription over RXRE-mediated (RXRα homodimer) transcription.","method":"Co-crystal structure (X-ray crystallography), transactivation assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures of both receptor LBDs with ligand plus functional transactivation assays, single lab","pmids":["22140563"],"is_preprint":false},{"year":2013,"finding":"Crystal structure of the PXR/RXRα ligand-binding domain heterotetramer at 2.8 Å resolution reveals an unprecedented heterotetramer arrangement; both PXR and RXRα bind SRC-1 coregulator with higher affinity as part of this complex than as monomers; full-length receptors show defined binding preferences for direct and everted repeat DNA elements.","method":"X-ray crystallography, coregulator binding assay, recombinant full-length receptor DNA binding assay","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus functional coregulator binding assay plus DNA binding characterization","pmids":["23602807"],"is_preprint":false},{"year":2014,"finding":"Crystal structure of the RXRα-LXRβ heterodimer on its cognate AGGTCA DR4 element reveals an extended X-shaped arrangement with crossed DNA- and ligand-binding domains, contrasting with the parallel domain arrangement of NRs on DR1 elements; LXRβ uses auxiliary DNA contacts and RXRα adapts flexibly to the heterodimeric complex.","method":"X-ray crystallography","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with direct structural comparison to other NR complexes","pmids":["24561505"],"is_preprint":false},{"year":2014,"finding":"Sulindac analogs K-8008 and K-8012 bind to a novel site on the RXRα LBD (distinct from the classical ligand-binding pocket) in tetrameric RXRα, inhibit tRXRα/p85α interaction, suppress AKT activation and induce apoptosis; crystal structures define this non-canonical binding mechanism.","method":"X-ray crystallography, Co-IP, AKT activation assay, apoptosis assay","journal":"Chemistry & biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus functional assays confirming binding at novel site","pmids":["24704507"],"is_preprint":false},{"year":2015,"finding":"Nitrostyrene derivatives bind to RXRα through the nitro group interacting with Cys432, activating Gal4-DBD-RXRα-LBD transactivation; they inhibit tRXRα interaction with TRAF2, reduce TNFα-induced ubiquitination of RIP1, and potently inhibit TNFα/NF-κB signaling in a tRXRα-dependent manner.","method":"Ligand binding assay, site-directed mutagenesis (Cys432 substitution), transactivation assay, Co-IP, ubiquitination assay, NF-κB reporter assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis identifying Cys432, functional assays with multiple orthogonal readouts","pmids":["25795708"],"is_preprint":false},{"year":2017,"finding":"Crystal structure of multi-domain RARβ-RXRα heterodimer bound to DNA, ligands, and coactivator peptides reveals that RARβ LBD and DBD are physically connected to foster allosteric signal transmission; RXRα maintains flexible loosely organized domains, while heterodimerization partners use their LBD surface to form domain-domain interactions with DBDs.","method":"X-ray crystallography, hydrogen-deuterium exchange mass spectrometry, mutagenesis, functional assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — multi-domain crystal structure plus HDX-MS plus mutagenesis plus functional studies in one study","pmids":["29021580"],"is_preprint":false},{"year":2017,"finding":"Recurrent RXRA S427F/Y mutations in bladder cancer allosterically activate the PPARγ/RXRα heterodimer; structure-function studies show the substitution allosterically regulates the PPAR AF2 domain via an aromatic interaction with the terminal tyrosine in PPARs; mutant RXRA drives growth-factor-independent urothelial proliferation reversible by PPAR inhibition.","method":"Structure-function mutagenesis, enhancer/promoter reporter assays, bladder organoid growth assay, PPAR inhibitor treatment","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — mechanistic structure-function study with organoid functional validation and pharmacological rescue","pmids":["29143738"],"is_preprint":false},{"year":2017,"finding":"Berberine directly binds RXRα at a unique region (residues Gln275, Arg316, Arg371) distinct from the classical 9-cis-RA binding pocket, promoting RXRα interaction with nuclear β-catenin and leading to c-Cbl-mediated degradation of β-catenin; berberine suppresses colon xenograft growth in an RXRα-dependent manner.","method":"Direct binding assay, site-directed mutagenesis, Co-IP, protein degradation assay, xenograft model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — identified binding residues by mutagenesis, confirmed with Co-IP and in vivo RXRα-dependent tumor suppression","pmids":["28846104"],"is_preprint":false},{"year":2018,"finding":"FXR/RXRα LBD heterodimer crystal structures show that both FXR and RXRα bind SRC-1 coregulator with higher affinity in the heterodimer than as monomers; heterodimerization and ligand binding induce conformational changes in FXR helix 11 C-terminus affecting coactivator binding surface stability.","method":"X-ray crystallography, coregulator binding affinity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus quantitative coregulator binding assay","pmids":["30275017"],"is_preprint":false},{"year":2018,"finding":"RXRα is phosphorylated at its N-terminal A/B domain by Cdk1 at the onset of mitosis, triggering its translocation to the centrosome where phosphorylated RXRα (p-RXRα) interacts with PLK1 through its N-terminal A/B domain to promote PLK1 activation, centrosome maturation, and mitotic progression.","method":"Live cell imaging, subcellular fractionation, Co-IP, phosphorylation assays, Cdk1 activity assay, kinase inhibitor studies","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — identified phosphorylation site (Cdk1), direct interaction with PLK1, localization with functional consequence, replicated in cancer cells and animal models","pmids":["33321102"],"is_preprint":false},{"year":2018,"finding":"lncRNA DANCR binds RXRA and increases its serine 49/78 phosphorylation via GSK3β, resulting in activation of PIK3CA transcription and enhanced PI3K/AKT signaling in triple-negative breast cancer.","method":"RNA-protein binding assay, phosphorylation assay, reporter assay, knockdown/overexpression in vitro and in vivo","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, identified phosphorylation sites and kinase, functional knockdown confirmed, but mechanism somewhat indirect","pmids":["30518934"],"is_preprint":false},{"year":2018,"finding":"RXRA knockdown in senescent cells induces ITPR2-MCU calcium signaling, leading to ROS production, DNA damage, and p53-dependent cellular senescence; RXRA overexpression decreases DNA damage and delays replicative senescence.","method":"siRNA screen, knockdown/overexpression, calcium signaling measurement, ROS assay, DNA damage markers","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA screen identified RXRA, functional validation with KD and OE, mechanistic pathway placed via ITPR2-MCU axis, single lab","pmids":["30216632"],"is_preprint":false},{"year":2019,"finding":"Truncated RXRα (tRXRα) expressed in myeloid cells interacts extensively with TRAF6 in the cytoplasm of macrophages, leading to TRAF6 ubiquitination and NF-κB activation, which induces IL-6 secretion and STAT3 activation to promote colitis-associated colorectal tumorigenesis.","method":"Transgenic mouse model, Co-IP, ubiquitination assay, cytokine measurement, NF-κB reporter assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic in vivo model plus mechanistic Co-IP and ubiquitination assays identifying TRAF6 interaction","pmids":["30931933"],"is_preprint":false},{"year":2020,"finding":"Qki serves as a coactivator of the PPARβ-RXRα complex in oligodendrocytes, controlling transcription of lipid metabolism genes (especially fatty acid desaturation and elongation) required for mature myelin lipid maintenance; Qki depletion causes rapid demyelination rescuable by PPARβ/RXR agonists.","method":"Oligodendrocyte-specific Qki knockout, Co-IP, transcriptome analysis, pharmacological rescue with PPARβ/RXR agonists, high-fat diet rescue","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO, coactivator interaction by Co-IP, pharmacological and dietary rescue, human disease correlation","pmids":["32202512"],"is_preprint":false},{"year":2021,"finding":"RXRα agonist SR11237 destabilizes the RXRα homodimer but promotes PPARγ:RXRα heterodimer formation; incorporation of PPARγ into the heterodimer results in substantial gain in coactivator CBP-1 affinity even without ligands, and SR11237 indirectly promotes coactivator binding to PPARγ by shifting RXRα oligomerization preference.","method":"FRET-based coactivator recruitment assay, RXRα LBD mutagenesis (coactivator-binding-deficient mutant), heterodimer formation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis separating coactivator binding from dimerization, quantitative FRET assays demonstrating allosteric mechanism","pmids":["34081964"],"is_preprint":false},{"year":2022,"finding":"JNK2α phosphorylates RXRα at Ser260 in vivo; hepatocyte-specific expression of phosphorylation-site mutant RXRα demonstrates that Ser260 phosphorylation is required for JNK2α-mediated suppression of FGF21 gene expression and metabolic dysregulation.","method":"Quantitative phosphoproteomics, hepatocyte-specific knock-in of wild-type vs. mutant RXRα (Ser260 site), Fgf21 expression measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — phosphoproteomic identification of site, genetic validation using site-specific mutant knock-in mice","pmids":["36282921"],"is_preprint":false},{"year":2023,"finding":"RXRα ligands activate Nurr1-RXRα transcription through a mechanism involving weakening of the Nurr1-RXRα LBD heterodimer affinity and heterodimer dissociation (PPI inhibition), releasing a transcriptionally active Nurr1 monomer from a repressive complex; this is distinct from classical agonist mechanisms and correlates with RXRα homodimer antagonism rather than agonism.","method":"NMR spectroscopy, protein-protein interaction assay, cellular transcription assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR structural data plus PPI assay plus cellular transcription assay, mechanistic paradigm established with multiple orthogonal methods","pmids":["37102494"],"is_preprint":false},{"year":1999,"finding":"Dexamethasone increases RXRα mRNA and protein expression in primary rat hepatocytes, and adenoviral overexpression of RXRα enhances T3-dependent type I 5'-deiodinase mRNA induction, demonstrating that glucocorticoid-induced RXRα upregulation augments thyroid hormone receptor signaling by increasing the availability of this obligatory heterodimerization partner.","method":"Northern blot, Western blot, EMSA, adenoviral overexpression, primary hepatocyte culture","journal":"Journal of molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple methods (RNA, protein, EMSA, gain-of-function) demonstrating mechanism, multiple T3-target genes tested","pmids":["9924183"],"is_preprint":false},{"year":2006,"finding":"RXRα down-regulation is required for neutrophil differentiation from granulocyte/monocyte progenitors; ectopic RXRα expression inhibits granulopoiesis and redirects G-CSF-dependent granulocyte differentiation to the monocyte lineage; dominant-negative RXRα promotes late-stage granulocyte generation in vitro and in vivo.","method":"Ectopic RXRα overexpression, dominant-negative RXRα, human in vitro myeloid cultures, in vivo reconstituted mouse model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain and loss of function in both in vitro and in vivo models, lineage fate switching as phenotypic readout","pmids":["17018855"],"is_preprint":false},{"year":2009,"finding":"PRKAR1A-RARα leukemic transformation critically depends on RXRα interaction: point mutations eliminating RXRα interaction with the RARα portion of the fusion protein, shRNA knockdown of RXRα, or RXRα agonist treatment all reduce transformation capability in murine bone marrow retroviral transduction assay.","method":"Bone marrow retroviral transduction/transformation assay, gel-shift assay, point mutagenesis, shRNA knockdown","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (mutagenesis, shRNA, pharmacology) all converging on RXRα requirement for transformation","pmids":["19965660"],"is_preprint":false},{"year":2008,"finding":"Retinol treatment increases RXRα-β-catenin protein interaction and triggers relocation of both proteins to the cytosol; RXRα lacking the AF-1 and DNA-binding domains abolishes β-catenin co-purification and proteasomal degradation of β-catenin, establishing that RXRα/β-catenin binding is required for proteasomal degradation of β-catenin.","method":"Co-immunoprecipitation, domain deletion mutant transfection, proteasome inhibitor treatment, subcellular fractionation","journal":"Nutrition and cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus domain deletion mutant establishing structural requirement, single lab","pmids":["18444141"],"is_preprint":false},{"year":2021,"finding":"PPARα/RXRα complex promotes proteasomal degradation of HNF4α in the presence of RXRα, downregulating amino acid catabolism genes in the liver; chromatin immunoprecipitation shows HNF4α binds the SDS promoter, and RXRα presence is essential for PPARα-mediated repression of this activity.","method":"PPARα knockout mouse model, chromatin immunoprecipitation, protein degradation assay, gene expression analysis","journal":"Metabolism: clinical and experimental","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse plus ChIP plus degradation assay, single lab","pmids":["33422545"],"is_preprint":false},{"year":2023,"finding":"SILENCING RXRA in A431 squamous carcinoma cells only partially reduces 1,25(OH)2D3-induced differentially expressed genes at 24 h (unlike VDR knockout which abolishes the response), and classic 1,25(OH)2D3 targets CYP24A1 and CAMP are regulated in an RXRA-independent manner, demonstrating that a subset of VDR genomic actions do not require RXRA.","method":"RXRA gene silencing/knockout, transcriptome analysis, immunofluorescence co-localization","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with genome-wide transcriptome readout, but negative/partial finding with RXRA","pmids":["38123121"],"is_preprint":false},{"year":2021,"finding":"RXRA directly activates the PLD1 promoter in cervical cancer cells; LINC00511 binds RXRA (demonstrated by RNA immunoprecipitation) and recruits it to the PLD1 promoter (shown by chromatin immunoprecipitation), upregulating PLD1 expression to promote cervical cancer cell proliferation.","method":"RNA immunoprecipitation, chromatin immunoprecipitation, dual-luciferase reporter assay, siRNA knockdown","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal RNA-IP and ChIP plus reporter assay, single lab","pmids":["32067228"],"is_preprint":false},{"year":2021,"finding":"TET1-mediated DNA demethylation at the Rxra locus promotes RXRα expression during adipogenesis; Tet1 knockout decreases 5hmC at Rxra, reduces RXRα expression, and impairs adipocyte differentiation; RXRα agonist partially rescues the Tet1 KO adipogenesis defect.","method":"TET1 knockout, 5mC/5hmC DNA immunoprecipitation, RNA-seq, RXRα agonist rescue","journal":"Biochimica et biophysica acta. Molecular and cell biology of lipids","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with epigenomic readout and pharmacological rescue, single lab","pmids":["33684567"],"is_preprint":false},{"year":2020,"finding":"Qki acts as coactivator of PPARβ-RXRα: Qki depletion in oligodendrocytes specifically reduces myelin lipid (monounsaturated and very-long-chain fatty acids) without affecting myelin proteins, and neurological deficits are alleviated by high-fat diet or PPARβ/RXR agonist treatment.","method":"Oligodendrocyte-specific Qki KO, lipidomics, PPARβ/RXR agonist treatment, high-fat diet rescue","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO with lipidomics, coactivator interaction by Co-IP, multiple rescue approaches, human MS correlation","pmids":["32202512"],"is_preprint":false},{"year":2013,"finding":"RXRα down-regulation in senescent macrophages mediates elevated COX2 expression and PGE2 production via increased NF-κB activity; systemic treatment of young mice with RXRα antagonist HX531 increases COX2, TNF-α, and IL-6 expression in splenocytes, establishing RXRα as a suppressor of NF-κB-driven inflammation in macrophages.","method":"Macrophage senescence model, COX2/PGE2 measurement, RXRα knockdown/antagonist treatment in vivo and in vitro","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — functional assays with pharmacological tools plus in vivo antagonist, mechanistic pathway placed, single lab","pmids":["24051096"],"is_preprint":false},{"year":2023,"finding":"FABP7 promotes glioblastoma stem cell migration through nuclear delivery of polyunsaturated fatty acids (PUFAs) to RXRα; FABP7-mediated activation of RXRα upregulates SOX2 and ZEB1 (demonstrated by gel shift and luciferase reporter assays), driving a stationary-to-migratory transition in GSCs.","method":"Gel shift assay, luciferase reporter assay, xenograft migration model, single-cell RNA sequencing","journal":"Neuro-oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gel shift and reporter assays establishing FABP7→RXRα→SOX2/ZEB1 pathway, in vivo xenograft validation, single lab","pmids":["37499046"],"is_preprint":false}],"current_model":"RXRα is a nuclear receptor that functions primarily as an obligatory heterodimerization partner for numerous other nuclear receptors (RAR, T3R, VDR, PPAR, LXR, FXR, PXR, CAR, Nurr1, and others), binding to direct-repeat DNA response elements to regulate transcription; its canonical ligand is 9-cis retinoic acid, but it can also be activated by DHA and other ligands at its classical LBD pocket or by small molecules at novel surface sites; in addition to its nuclear transcriptional role, RXRα is proteolytically truncated to generate tRXRα in tumors, which interacts with PI3K/p85α and TRAF6 in the cytoplasm to activate AKT and NF-κB signaling; at mitosis onset, Cdk1 phosphorylates RXRα at its N-terminal A/B domain, causing centrosomal translocation where it activates PLK1 to promote mitotic progression; JNK2α phosphorylates RXRα at Ser260 to suppress hepatic FGF21 expression; and RXRα is essential in vivo for cardiac morphogenesis (non-cell-autonomously), skin keratinocyte homeostasis, xenobiotic metabolism via CAR/PXR, neutrophil differentiation, and myelin lipid maintenance via PPARβ-RXRα coactivation by Qki."},"narrative":{"mechanistic_narrative":"RXRα is a nuclear receptor that operates as the obligatory heterodimerization partner for a broad array of nuclear receptors—RAR, T3R, VDR, PXR, CAR, PPARγ, PPARβ, PPARα, LXRβ, FXR, and Nurr1—enabling their stable binding to direct-repeat DNA response elements and ligand-dependent transcriptional control [PMID:1314167, PMID:11803135, PMID:23602807, PMID:24561505, PMID:29021580, PMID:30275017]. Its proximate endogenous ligand is 9-cis retinoic acid [PMID:1309942], and it is additionally activated by docosahexaenoic acid and a chemically diverse set of small molecules that bind either the classical L-shaped ligand pocket or non-canonical surface sites including Cys432 and an alternate region centered on Gln275/Arg316/Arg371 [PMID:12844485, PMID:22140563, PMID:24704507, PMID:25795708, PMID:28846104]. Within heterodimers RXRα acts as an allosteric platform: its oligomerization state and ligand occupancy tune coactivator (SRC-1, CBP) recruitment to the partner receptor, and partner LBDs form domain–domain contacts that transmit allosteric signals across the complex [PMID:23602807, PMID:29021580, PMID:30275017, PMID:34081964]; ligand-driven dissociation of the Nurr1–RXRα heterodimer represents a distinct PPI-inhibition mode of transcriptional activation [PMID:37102494]. Genetically, RXRα is essential in vivo for cardiac morphogenesis, where it acts non-cell-autonomously in a non-myocyte lineage to drive cardiomyocyte proliferation in a gene-dosage-dependent manner [PMID:7926783, PMID:8823298, PMID:9550727], for keratinocyte and hair-follicle homeostasis via RXRα/VDR complexes [PMID:11171393], for CAR/PXR-dependent hepatic xenobiotic metabolism [PMID:11803135], for neutrophil-versus-monocyte lineage decisions [PMID:17018855], and for PPARβ-RXRα-driven myelin lipid maintenance coactivated by Qki [PMID:32202512]. Beyond transcription, RXRα is subject to regulatory phosphorylation: Cdk1 phosphorylates its N-terminal A/B domain at mitotic onset, driving centrosomal translocation and PLK1 activation to promote mitotic progression [PMID:33321102], and JNK2α phosphorylates Ser260 to suppress hepatic FGF21 expression [PMID:36282921]. In tumors, an N-terminally truncated cytoplasmic form (tRXRα) interacts with the PI3K p85α subunit to activate AKT and with TRAF6 to drive NF-κB/IL-6/STAT3 signaling, linking RXRα to survival and inflammatory tumorigenesis; sulindac analogs and nitrostyrene derivatives that bind RXRα disrupt these interactions and restore apoptosis [PMID:20541701, PMID:24704507, PMID:25795708, PMID:30931933]. Recurrent RXRA S427F/Y mutations allosterically activate the PPARγ/RXRα heterodimer to drive growth-factor-independent urothelial proliferation [PMID:29143738].","teleology":[{"year":1992,"claim":"Establishing RXRα's endogenous ligand and its core biochemical role answered what activates the receptor and how it engages DNA, defining it as a ligand-controlled heterodimeric transcription factor.","evidence":"Ligand trapping/direct binding for 9-cis-RA, plus biochemical co-purification and EMSA with RAR/T3R/VDR","pmids":["1309942","1314167","1329088"],"confidence":"High","gaps":["Full repertoire of physiological heterodimer partners not yet defined","Structural basis of DNA-element selectivity not addressed"]},{"year":1998,"claim":"Knockout and chimera studies answered whether RXRα is genetically required for development and where it acts, revealing an essential non-cell-autonomous role in cardiac morphogenesis with gene-dosage sensitivity.","evidence":"Conventional and heterozygous RXRα knockout mice plus RXRα-/- ES cell chimera analysis","pmids":["7926783","8823298","9550727"],"confidence":"High","gaps":["Identity of the non-myocyte signal induced by RXRα not defined","Downstream transcriptional targets in the responsible lineage unresolved"]},{"year":2002,"claim":"Tissue-specific knockouts answered which physiological partner-receptor programs depend on RXRα in vivo, establishing it as the required dimer partner for VDR (hair cycling), CAR/PXR (xenobiotic metabolism), and PPARγ pathways.","evidence":"Keratinocyte- and hepatocyte-specific RXRα knockouts; cytotrophoblast reporter and invasion assays","pmids":["11171393","11803135","11564716","11600579","12145812"],"confidence":"High","gaps":["Whether RXRα ligand occupancy is required versus a permissive scaffold role not separated for each partner","Mechanism of cytokine-driven RXRα downregulation in cholestasis incomplete"]},{"year":2006,"claim":"Gain- and loss-of-function in myeloid cells answered whether RXRα levels instruct lineage choice, showing its down-regulation is required for neutrophil differentiation and its persistence redirects cells toward the monocyte lineage.","evidence":"Ectopic and dominant-negative RXRα in human myeloid cultures and reconstituted mouse models","pmids":["17018855"],"confidence":"High","gaps":["Target genes mediating the lineage switch not defined","Heterodimer partner responsible for the granulopoietic block unidentified"]},{"year":2003,"claim":"Ligand-activation assays answered whether RXRα senses dietary fatty acids, identifying DHA as a specific RXRα-activating ligand distinct from PPARγ activation.","evidence":"Mammalian one-hybrid and reporter assays with RXRα versus PPARγ antagonists in colonocytes","pmids":["12844485"],"confidence":"Medium","gaps":["Direct binding affinity of DHA for RXRα not measured","Physiological relevance of DHA-RXRα signaling in vivo not established"]},{"year":2010,"claim":"Discovery of cytoplasmic truncated tRXRα answered how RXRα contributes to tumor survival outside transcription, linking it to PI3K/p85α-driven AKT signaling that is druggable by sulindac analogs.","evidence":"Reciprocal Co-IP, COX-inactive analog K-80003, AKT and apoptosis assays, tumor model","pmids":["20541701"],"confidence":"High","gaps":["Protease generating tRXRα not identified","Determinants of cytoplasmic versus nuclear partitioning unresolved"]},{"year":2017,"claim":"A series of crystal structures answered how heterodimer architecture and ligand binding are coordinated, revealing partner-specific DNA-element geometries, allosteric domain coupling, and cooperative coregulator recruitment.","evidence":"X-ray structures of RXRα with PXR, LXRβ, FXR, RARβ, and PPARγ LBDs plus HDX-MS, coregulator binding, and DNA-binding assays","pmids":["23602807","24561505","30275017","29021580","22140563"],"confidence":"High","gaps":["Full-length heterodimer-on-DNA conformational dynamics in solution not fully resolved","How distinct response-element geometries map to in vivo target selection incomplete"]},{"year":2017,"claim":"Mapping non-canonical small-molecule binding sites answered how diverse compounds modulate RXRα beyond the classical pocket, defining Cys432 and an alternate Gln275/Arg316/Arg371 region as functional sites controlling tRXRα interactions and β-catenin degradation.","evidence":"Crystallography, site-directed mutagenesis, Co-IP, ubiquitination, NF-κB and xenograft assays for sulindac analogs, nitrostyrenes, and berberine","pmids":["24704507","25795708","28846104"],"confidence":"High","gaps":["Endogenous ligands for these surface sites unknown","Selectivity of these compounds across nuclear receptors not fully characterized"]},{"year":2017,"claim":"Characterizing recurrent RXRA S427F/Y mutations answered how RXRα itself can be an oncogenic driver, showing the substitution allosterically activates the PPARγ/RXRα heterodimer to drive ligand-independent urothelial proliferation.","evidence":"Structure-function mutagenesis, reporter assays, bladder organoid growth, and PPAR inhibitor rescue","pmids":["29143738"],"confidence":"High","gaps":["Frequency and tissue range of the activating mechanism beyond bladder not defined","Whether the mutant alters other heterodimers not tested"]},{"year":2022,"claim":"Phosphorylation studies answered how kinase signaling repurposes RXRα, identifying Cdk1-driven centrosomal PLK1 activation in mitosis and JNK2α-Ser260 suppression of hepatic FGF21.","evidence":"Phosphoproteomics, Cdk1/JNK2α phosphorylation assays, PLK1 Co-IP, and Ser260 knock-in mice","pmids":["33321102","36282921","30518934"],"confidence":"High","gaps":["Interplay between these phosphorylation events and transcriptional output not integrated","Whether centrosomal RXRα requires its DNA-binding function unresolved"]},{"year":2020,"claim":"Coactivator and metabolic studies answered how RXRα heterodimers control lipid programs, showing Qki coactivates PPARβ-RXRα to maintain myelin lipids and that allosteric heterodimer formation gains coactivator affinity even without ligand.","evidence":"Oligodendrocyte-specific Qki knockout with lipidomics and agonist rescue; FRET coactivator-recruitment and RXRα oligomerization assays","pmids":["32202512","34081964","33684567","33422545"],"confidence":"High","gaps":["How RXRα oligomerization state is set in vivo not defined","Generality of the ligand-independent coactivator gain across partners untested"]},{"year":2023,"claim":"Newer mechanistic and disease-context studies answered how RXRα ligands act through dimer dissociation and how lipid carriers and lncRNAs route RXRα into cancer programs, expanding the activation paradigm beyond classical agonism.","evidence":"NMR and PPI assays for Nurr1-RXRα dissociation; FABP7 PUFA delivery, RNA-IP/ChIP for LINC00511 and DANCR, and senescence calcium-signaling assays","pmids":["37102494","37499046","32067228","30216632"],"confidence":"Medium","gaps":["Several cancer-context mechanisms rest on single-lab data","How dimer-dissociation activation generalizes to other RXRα partners unclear"]},{"year":null,"claim":"It remains unresolved how RXRα's nuclear transcriptional, cytoplasmic tRXRα, and centrosomal/phosphorylation-dependent functions are coordinately controlled within a single cell, and what governs the switch between heterodimer scaffold, allosteric coactivator platform, and non-genomic signaling roles.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking RXRα localization, proteolysis, and phosphorylation states","Protease and trafficking determinants of tRXRα generation unidentified","In vivo balance of ligand-dependent versus permissive heterodimer functions unquantified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,3,7,18,19,36,40]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,3,14,15,36]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,11,13,40]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,11,13]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,27]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,3,7,30,36]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[12,25,33]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[22]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,14,18,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,4,5,6,31]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[9,26,28,34,37,38]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[12,17,25]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[12,19,25,40]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[22]}],"complexes":["RXRα/PPARγ heterodimer","RXRα/VDR heterodimer","RXRα/RAR heterodimer","PXR/RXRα LBD heterotetramer"],"partners":["RARA","PPARG","VDR","PXR","LXRB","FXR","PLK1","TRAF6"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P19793","full_name":"Retinoic acid receptor RXR-alpha","aliases":["Nuclear receptor subfamily 2 group B member 1","Retinoid X receptor alpha"],"length_aa":462,"mass_kda":50.8,"function":"Receptor for retinoic acid that acts as a transcription factor (PubMed:10874028, PubMed:11162439, PubMed:11915042, PubMed:37478846). Forms homo- or heterodimers with retinoic acid receptors (RARs) and binds to target response elements in response to their ligands, all-trans or 9-cis retinoic acid, to regulate gene expression in various biological processes (PubMed:10195690, PubMed:11162439, PubMed:11915042, PubMed:16107141, PubMed:17761950, PubMed:18800767, PubMed:19167885, PubMed:28167758, PubMed:37478846). The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5 to regulate transcription (PubMed:10195690, PubMed:11162439, PubMed:11915042, PubMed:17761950, PubMed:28167758). The high affinity ligand for retinoid X receptors (RXRs) is 9-cis retinoic acid (PubMed:1310260). In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone deacetylation, chromatin condensation and transcriptional suppression (PubMed:20215566). On ligand binding, the corepressors dissociate from the receptors and coactivators are recruited leading to transcriptional activation (PubMed:20215566, PubMed:37478846, PubMed:9267036). Serves as a common heterodimeric partner for a number of nuclear receptors, such as RARA, RARB and PPARA (PubMed:10195690, PubMed:11915042, PubMed:28167758, PubMed:29021580). The RXRA/RARB heterodimer can act as a transcriptional repressor or transcriptional activator, depending on the RARE DNA element context (PubMed:29021580). The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes (PubMed:10195690). Together with RARA, positively regulates microRNA-10a expression, thereby inhibiting the GATA6/VCAM1 signaling response to pulsatile shear stress in vascular endothelial cells (PubMed:28167758). Acts as an enhancer of RARA binding to RARE DNA element (PubMed:28167758). May facilitate the nuclear import of heterodimerization partners such as VDR and NR4A1 (PubMed:12145331, PubMed:15509776). Promotes myelin debris phagocytosis and remyelination by macrophages (PubMed:26463675). Plays a role in the attenuation of the innate immune system in response to viral infections, possibly by negatively regulating the transcription of antiviral genes such as type I IFN genes (PubMed:25417649). Involved in the regulation of calcium signaling by repressing ITPR2 gene expression, thereby controlling cellular senescence (PubMed:30216632)","subcellular_location":"Nucleus; Cytoplasm; Mitochondrion","url":"https://www.uniprot.org/uniprotkb/P19793/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RXRA","classification":"Not Classified","n_dependent_lines":76,"n_total_lines":1208,"dependency_fraction":0.06291390728476821},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RXRA","total_profiled":1310},"omim":[{"mim_id":"617870","title":"CENTROSOMAL PROTEIN 350; CEP350","url":"https://www.omim.org/entry/617870"},{"mim_id":"617597","title":"RETINOL SATURASE; RETSAT","url":"https://www.omim.org/entry/617597"},{"mim_id":"617386","title":"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 5, PSEUDOGENE; NR1H5P","url":"https://www.omim.org/entry/617386"},{"mim_id":"616477","title":"NUCLEAR RECEPTOR-BINDING FACTOR 2; NRBF2","url":"https://www.omim.org/entry/616477"},{"mim_id":"615354","title":"LIGAND-DEPENDENT NUCLEAR RECEPTOR-INTERACTING FACTOR 1; LRIF1","url":"https://www.omim.org/entry/615354"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RXRA"},"hgnc":{"alias_symbol":["NR2B1","RXRalpha","RXR-alpha"],"prev_symbol":[]},"alphafold":{"accession":"P19793","domains":[{"cath_id":"3.30.50.10","chopping":"131-203","consensus_level":"high","plddt":96.723,"start":131,"end":203},{"cath_id":"1.10.565.10","chopping":"228-248_261-454","consensus_level":"high","plddt":93.3326,"start":228,"end":454}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P19793","model_url":"https://alphafold.ebi.ac.uk/files/AF-P19793-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P19793-F1-predicted_aligned_error_v6.png","plddt_mean":75.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RXRA","jax_strain_url":"https://www.jax.org/strain/search?query=RXRA"},"sequence":{"accession":"P19793","fasta_url":"https://rest.uniprot.org/uniprotkb/P19793.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P19793/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P19793"}},"corpus_meta":[{"pmid":"1309942","id":"PMC_1309942","title":"9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha.","date":"1992","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1309942","citation_count":1210,"is_preprint":false},{"pmid":"7926783","id":"PMC_7926783","title":"RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis.","date":"1994","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7926783","citation_count":531,"is_preprint":false},{"pmid":"1314167","id":"PMC_1314167","title":"RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors.","date":"1992","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1314167","citation_count":433,"is_preprint":false},{"pmid":"25592151","id":"PMC_25592151","title":"Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway.","date":"2015","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25592151","citation_count":315,"is_preprint":false},{"pmid":"8799145","id":"PMC_8799145","title":"RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8799145","citation_count":185,"is_preprint":false},{"pmid":"11171393","id":"PMC_11171393","title":"RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11171393","citation_count":165,"is_preprint":false},{"pmid":"11564716","id":"PMC_11564716","title":"PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation.","date":"2001","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11564716","citation_count":148,"is_preprint":false},{"pmid":"8823298","id":"PMC_8823298","title":"RXR alpha deficiency confers genetic susceptibility for aortic sac, conotruncal, atrioventricular cushion, and ventricular muscle defects in mice.","date":"1996","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8823298","citation_count":145,"is_preprint":false},{"pmid":"11600579","id":"PMC_11600579","title":"PPARgamma/RXRalpha heterodimers control human trophoblast invasion.","date":"2001","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11600579","citation_count":126,"is_preprint":false},{"pmid":"28740126","id":"PMC_28740126","title":"Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28740126","citation_count":122,"is_preprint":false},{"pmid":"28846104","id":"PMC_28846104","title":"Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/28846104","citation_count":117,"is_preprint":false},{"pmid":"20541701","id":"PMC_20541701","title":"NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.","date":"2010","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/20541701","citation_count":114,"is_preprint":false},{"pmid":"11779144","id":"PMC_11779144","title":"Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11779144","citation_count":100,"is_preprint":false},{"pmid":"24561505","id":"PMC_24561505","title":"Structure of the retinoid X receptor α-liver X receptor β (RXRα-LXRβ) heterodimer on DNA.","date":"2014","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24561505","citation_count":90,"is_preprint":false},{"pmid":"23990020","id":"PMC_23990020","title":"Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis.","date":"2013","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/23990020","citation_count":89,"is_preprint":false},{"pmid":"37579917","id":"PMC_37579917","title":"Forsythiaside A alleviates acute lung injury by inhibiting inflammation and epithelial barrier damages in lung and colon through PPAR-γ/RXR-α complex.","date":"2023","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/37579917","citation_count":81,"is_preprint":false},{"pmid":"30518934","id":"PMC_30518934","title":"LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30518934","citation_count":79,"is_preprint":false},{"pmid":"12844485","id":"PMC_12844485","title":"Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes.","date":"2003","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/12844485","citation_count":76,"is_preprint":false},{"pmid":"29021580","id":"PMC_29021580","title":"The quaternary architecture of RARβ-RXRα heterodimer facilitates domain-domain signal transmission.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29021580","citation_count":73,"is_preprint":false},{"pmid":"28348207","id":"PMC_28348207","title":"Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28348207","citation_count":72,"is_preprint":false},{"pmid":"1329088","id":"PMC_1329088","title":"Retinoid X receptor RXR alpha binds to and trans-activates the hepatitis B virus enhancer.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1329088","citation_count":67,"is_preprint":false},{"pmid":"11803135","id":"PMC_11803135","title":"The role of hepatocyte RXR alpha in xenobiotic-sensing nuclear receptor-mediated pathways.","date":"2002","source":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/11803135","citation_count":67,"is_preprint":false},{"pmid":"22140563","id":"PMC_22140563","title":"Molecular determinants of magnolol targeting both RXRα and PPARγ.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22140563","citation_count":67,"is_preprint":false},{"pmid":"29143738","id":"PMC_29143738","title":"Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29143738","citation_count":64,"is_preprint":false},{"pmid":"12145812","id":"PMC_12145812","title":"Organ-specific alterations in RAR alpha:RXR alpha abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis.","date":"2002","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/12145812","citation_count":64,"is_preprint":false},{"pmid":"23907847","id":"PMC_23907847","title":"Childhood bone mineral content is associated with methylation status of the RXRA promoter at birth.","date":"2014","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/23907847","citation_count":63,"is_preprint":false},{"pmid":"28241052","id":"PMC_28241052","title":"OSBPL10, RXRA and lipid metabolism confer African-ancestry protection against dengue haemorrhagic fever in admixed Cubans.","date":"2017","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/28241052","citation_count":62,"is_preprint":false},{"pmid":"32202512","id":"PMC_32202512","title":"Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32202512","citation_count":62,"is_preprint":false},{"pmid":"30216632","id":"PMC_30216632","title":"The nuclear receptor RXRA controls cellular senescence by regulating calcium signaling.","date":"2018","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/30216632","citation_count":56,"is_preprint":false},{"pmid":"9550727","id":"PMC_9550727","title":"The RXRalpha gene functions in a non-cell-autonomous manner during mouse cardiac morphogenesis.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9550727","citation_count":55,"is_preprint":false},{"pmid":"30275017","id":"PMC_30275017","title":"Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30275017","citation_count":55,"is_preprint":false},{"pmid":"30931933","id":"PMC_30931933","title":"Oncogenic potential of truncated RXRα during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30931933","citation_count":53,"is_preprint":false},{"pmid":"10675365","id":"PMC_10675365","title":"RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses.","date":"2000","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10675365","citation_count":52,"is_preprint":false},{"pmid":"23602807","id":"PMC_23602807","title":"Structural and functional analysis of the human nuclear xenobiotic receptor PXR in complex with RXRα.","date":"2013","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23602807","citation_count":50,"is_preprint":false},{"pmid":"16448862","id":"PMC_16448862","title":"Characterization of retinoid-X receptor genes rxra, rxrba, rxrbb and rxrg during zebrafish development.","date":"2006","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/16448862","citation_count":47,"is_preprint":false},{"pmid":"20145122","id":"PMC_20145122","title":"Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20145122","citation_count":47,"is_preprint":false},{"pmid":"12750559","id":"PMC_12750559","title":"Aberration in the expression of the retinoid receptor, RXRalpha, in prostate cancer.","date":"2003","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/12750559","citation_count":46,"is_preprint":false},{"pmid":"17018855","id":"PMC_17018855","title":"Down-regulation of RXRalpha expression is essential for neutrophil development from granulocyte/monocyte progenitors.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17018855","citation_count":45,"is_preprint":false},{"pmid":"17433077","id":"PMC_17433077","title":"Disruption of Rxra gene in thymocytes and T lymphocytes modestly alters lymphocyte frequencies, proliferation, survival and T helper type 1/type 2 balance.","date":"2007","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17433077","citation_count":43,"is_preprint":false},{"pmid":"26823026","id":"PMC_26823026","title":"Allosteric Pathways in the PPARγ-RXRα nuclear receptor complex.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26823026","citation_count":42,"is_preprint":false},{"pmid":"24704507","id":"PMC_24704507","title":"Sulindac-derived RXRα modulators inhibit cancer cell growth by binding to a novel site.","date":"2014","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/24704507","citation_count":41,"is_preprint":false},{"pmid":"26643981","id":"PMC_26643981","title":"RXRα, PXR and CAR xenobiotic receptors mediate the apoptotic and neurotoxic actions of nonylphenol in mouse hippocampal cells.","date":"2015","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26643981","citation_count":40,"is_preprint":false},{"pmid":"20944655","id":"PMC_20944655","title":"RXRα ablation in epidermal keratinocytes enhances UVR-induced DNA damage, apoptosis, and proliferation of keratinocytes and melanocytes.","date":"2010","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/20944655","citation_count":39,"is_preprint":false},{"pmid":"30321476","id":"PMC_30321476","title":"Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial.","date":"2019","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/30321476","citation_count":38,"is_preprint":false},{"pmid":"31874245","id":"PMC_31874245","title":"miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA.","date":"2019","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/31874245","citation_count":37,"is_preprint":false},{"pmid":"26727233","id":"PMC_26727233","title":"Coordinating Role of RXRα in Downregulating Hepatic Detoxification during Inflammation Revealed by Fuzzy-Logic Modeling.","date":"2016","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/26727233","citation_count":36,"is_preprint":false},{"pmid":"32067228","id":"PMC_32067228","title":"Promotion of cell autophagy and apoptosis in cervical cancer by inhibition of long noncoding RNA LINC00511 via transcription factor RXRA-regulated PLD1.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32067228","citation_count":35,"is_preprint":false},{"pmid":"9543171","id":"PMC_9543171","title":"Retinoid receptors expression in human term placenta: involvement of RXR alpha in retinoid induced-hCG secretion.","date":"1998","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/9543171","citation_count":35,"is_preprint":false},{"pmid":"36347997","id":"PMC_36347997","title":"Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation.","date":"2022","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/36347997","citation_count":34,"is_preprint":false},{"pmid":"25795708","id":"PMC_25795708","title":"Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB.","date":"2015","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25795708","citation_count":34,"is_preprint":false},{"pmid":"31710612","id":"PMC_31710612","title":"Tributyltin chloride (TBT) induces RXRA down-regulation and lipid accumulation in human liver cells.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31710612","citation_count":33,"is_preprint":false},{"pmid":"1358808","id":"PMC_1358808","title":"Mapping of the mouse Rxr loci encoding nuclear retinoid X receptors RXR alpha, RXR beta, and RXR gamma.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1358808","citation_count":33,"is_preprint":false},{"pmid":"19374686","id":"PMC_19374686","title":"RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism.","date":"2009","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19374686","citation_count":32,"is_preprint":false},{"pmid":"20307661","id":"PMC_20307661","title":"Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites.","date":"2010","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20307661","citation_count":32,"is_preprint":false},{"pmid":"34539418","id":"PMC_34539418","title":"α-Mangostin Induces Apoptosis and Inhibits Metastasis of Breast Cancer Cells via Regulating RXRα-AKT Signaling Pathway.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34539418","citation_count":31,"is_preprint":false},{"pmid":"9924183","id":"PMC_9924183","title":"Glucocorticoids increase retinoid-X receptor alpha (RXRalpha) expression and enhance thyroid hormone action in primary cultured rat hepatocytes.","date":"1999","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9924183","citation_count":31,"is_preprint":false},{"pmid":"33581653","id":"PMC_33581653","title":"Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.","date":"2021","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/33581653","citation_count":29,"is_preprint":false},{"pmid":"17194715","id":"PMC_17194715","title":"CAR2 displays unique ligand binding and RXRalpha heterodimerization characteristics.","date":"2006","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/17194715","citation_count":29,"is_preprint":false},{"pmid":"34081964","id":"PMC_34081964","title":"Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34081964","citation_count":28,"is_preprint":false},{"pmid":"28079136","id":"PMC_28079136","title":"SNP rs11185644 of RXRA gene is identified for dose-response variability to vitamin D3 supplementation: a randomized clinical trial.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28079136","citation_count":26,"is_preprint":false},{"pmid":"24051096","id":"PMC_24051096","title":"Elevated COX2 expression and PGE2 production by downregulation of RXRα in senescent macrophages.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24051096","citation_count":26,"is_preprint":false},{"pmid":"26494413","id":"PMC_26494413","title":"Targeting truncated RXRα for cancer therapy.","date":"2015","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/26494413","citation_count":25,"is_preprint":false},{"pmid":"31676441","id":"PMC_31676441","title":"PPARA/RXRA signalling regulates the fate of hepatic non-esterified fatty acids in a sheep model of maternal undernutrition.","date":"2019","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/31676441","citation_count":25,"is_preprint":false},{"pmid":"31297878","id":"PMC_31297878","title":"YAP1 regulates PPARG and RXR alpha expression to affect the proliferation and differentiation of ovine preadipocyte.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31297878","citation_count":25,"is_preprint":false},{"pmid":"35483561","id":"PMC_35483561","title":"Forsythiae Fructuse extracts alleviates LPS-induced acute lung injury in mice by regulating PPAR-γ/RXR-α in lungs and colons.","date":"2022","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35483561","citation_count":25,"is_preprint":false},{"pmid":"34239022","id":"PMC_34239022","title":"EGR1 and RXRA transcription factors link TGF-β pathway and CCL2 expression in triple negative breast cancer cells.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34239022","citation_count":24,"is_preprint":false},{"pmid":"36874033","id":"PMC_36874033","title":"Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXRα in vivo and in vitro.","date":"2023","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36874033","citation_count":24,"is_preprint":false},{"pmid":"24513686","id":"PMC_24513686","title":"Elevated methylation of the RXRA promoter region may be responsible for its downregulated expression in the myocardium of patients with TOF.","date":"2014","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/24513686","citation_count":23,"is_preprint":false},{"pmid":"35258399","id":"PMC_35258399","title":"Interleukin-17 promotes proliferation, migration, and invasion of trophoblasts via regulating PPAR-γ/RXR-α/Wnt signaling.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35258399","citation_count":22,"is_preprint":false},{"pmid":"25915942","id":"PMC_25915942","title":"MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25915942","citation_count":22,"is_preprint":false},{"pmid":"19965660","id":"PMC_19965660","title":"Leukemic transformation by the APL fusion protein PRKAR1A-RAR{alpha} critically depends on recruitment of RXR{alpha}.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19965660","citation_count":21,"is_preprint":false},{"pmid":"35417848","id":"PMC_35417848","title":"Panaxytriol upregulates CYP3A4 expression based on the interaction of PXR, CAR, HSP90α, and RXRα.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35417848","citation_count":20,"is_preprint":false},{"pmid":"34142331","id":"PMC_34142331","title":"Pharmacological Activation of RXR-α Promotes Hematoma Absorption via a PPAR-γ-dependent Pathway After Intracerebral Hemorrhage.","date":"2021","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/34142331","citation_count":20,"is_preprint":false},{"pmid":"21937108","id":"PMC_21937108","title":"RXRα and LXR activate two promoters in placenta- and tumor-specific expression of PLAC1.","date":"2011","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/21937108","citation_count":20,"is_preprint":false},{"pmid":"26575331","id":"PMC_26575331","title":"Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival.","date":"2016","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/26575331","citation_count":20,"is_preprint":false},{"pmid":"29228308","id":"PMC_29228308","title":"RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC).","date":"2018","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/29228308","citation_count":20,"is_preprint":false},{"pmid":"33684567","id":"PMC_33684567","title":"TET1 promotes RXRα expression and adipogenesis through DNA demethylation.","date":"2021","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/33684567","citation_count":19,"is_preprint":false},{"pmid":"30529222","id":"PMC_30529222","title":"Nuclear RXRα and RXRβ receptors exert distinct and opposite effects on RA-mediated neuroblastoma differentiation.","date":"2018","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/30529222","citation_count":19,"is_preprint":false},{"pmid":"23319938","id":"PMC_23319938","title":"Solution Structures of PPARγ2/RXRα Complexes.","date":"2012","source":"PPAR research","url":"https://pubmed.ncbi.nlm.nih.gov/23319938","citation_count":19,"is_preprint":false},{"pmid":"14611810","id":"PMC_14611810","title":"RXRalpha-regulated liver SAMe and GSH levels influence susceptibility to alcohol-induced hepatotoxicity.","date":"2003","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/14611810","citation_count":18,"is_preprint":false},{"pmid":"37102494","id":"PMC_37102494","title":"Molecular basis of ligand-dependent Nurr1-RXRα activation.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37102494","citation_count":17,"is_preprint":false},{"pmid":"37990410","id":"PMC_37990410","title":"Binding of Per- and Polyfluoroalkyl Substances (PFAS) to the PPARγ/RXRα-DNA Complex.","date":"2023","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/37990410","citation_count":17,"is_preprint":false},{"pmid":"23079705","id":"PMC_23079705","title":"PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms and lipid and lipoprotein levels in a Southern Brazilian population.","date":"2012","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23079705","citation_count":17,"is_preprint":false},{"pmid":"37246895","id":"PMC_37246895","title":"lncRNA RMST suppresses the progression of colorectal cancer by competitively binding to miR-27a-3p/RXRα axis and inactivating Wnt signaling pathway.","date":"2023","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/37246895","citation_count":17,"is_preprint":false},{"pmid":"30634084","id":"PMC_30634084","title":"Design, synthesis and biological evaluation of tetrazole-containing RXRα ligands as anticancer agents.","date":"2018","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30634084","citation_count":17,"is_preprint":false},{"pmid":"9144402","id":"PMC_9144402","title":"DNA binding preferences of PPAR alpha/RXR alpha heterodimers.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9144402","citation_count":17,"is_preprint":false},{"pmid":"18444141","id":"PMC_18444141","title":"Retinol Increases beta-catenin-RXRalpha binding leading to the increased proteasomal degradation of beta-catenin and RXRalpha.","date":"2008","source":"Nutrition and cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18444141","citation_count":17,"is_preprint":false},{"pmid":"37499046","id":"PMC_37499046","title":"Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXRα neurogenic pathway.","date":"2023","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37499046","citation_count":16,"is_preprint":false},{"pmid":"36282921","id":"PMC_36282921","title":"Phosphorylation of RXRα mediates the effect of JNK to suppress hepatic FGF21 expression and promote metabolic syndrome.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36282921","citation_count":16,"is_preprint":false},{"pmid":"26898458","id":"PMC_26898458","title":"IL-1β induced RXRα overexpression through activation of NF-κB signaling in gastric carcinoma.","date":"2016","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/26898458","citation_count":16,"is_preprint":false},{"pmid":"39225895","id":"PMC_39225895","title":"Inhibition of the RXRA-PPARα-FABP4 signaling pathway alleviates vascular cellular aging by an SGLT2 inhibitor in an atherosclerotic mice model.","date":"2024","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39225895","citation_count":15,"is_preprint":false},{"pmid":"33321102","id":"PMC_33321102","title":"Centrosomal Localization of RXRα Promotes PLK1 Activation and Mitotic Progression and Constitutes a Tumor Vulnerability.","date":"2020","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/33321102","citation_count":15,"is_preprint":false},{"pmid":"27445823","id":"PMC_27445823","title":"Phytochemicals Mediate the Expression and Activity of OCTN2 as Activators of the PPARγ/RXRα Pathway.","date":"2016","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27445823","citation_count":15,"is_preprint":false},{"pmid":"33422545","id":"PMC_33422545","title":"PPARα/RXRα downregulates amino acid catabolism in the liver via interaction with HNF4α promoting its proteasomal degradation.","date":"2021","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/33422545","citation_count":15,"is_preprint":false},{"pmid":"27042330","id":"PMC_27042330","title":"Genetic characterisation of PPARG, CEBPA and RXRA, and their influence on meat quality traits in cattle.","date":"2016","source":"Journal of animal science and technology","url":"https://pubmed.ncbi.nlm.nih.gov/27042330","citation_count":14,"is_preprint":false},{"pmid":"22827437","id":"PMC_22827437","title":"The PP2A-Aβ gene is regulated by multiple transcriptional factors including Ets-1, SP1/SP3, and RXRα/β.","date":"2012","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22827437","citation_count":14,"is_preprint":false},{"pmid":"31038949","id":"PMC_31038949","title":"Cytotoxic Components from Hypericum elodeoides Targeting RXRα and Inducing HeLa Cell Apoptosis through Caspase-8 Activation and PARP Cleavage.","date":"2019","source":"Journal of natural products","url":"https://pubmed.ncbi.nlm.nih.gov/31038949","citation_count":14,"is_preprint":false},{"pmid":"25479590","id":"PMC_25479590","title":"Flightless-1, a novel transcriptional modulator of PPARγ through competing with RXRα.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25479590","citation_count":14,"is_preprint":false},{"pmid":"36150542","id":"PMC_36150542","title":"Effects of PPAR-γ and RXR-α on mouse meibomian gland epithelial cells during inflammation induced by latanoprost.","date":"2022","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/36150542","citation_count":13,"is_preprint":false},{"pmid":"38123121","id":"PMC_38123121","title":"Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)2D3 in A431 squamous cell carcinoma.","date":"2023","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/38123121","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51418,"output_tokens":9462,"usd":0.148092,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20438,"output_tokens":5157,"usd":0.115557,"stage2_stop_reason":"end_turn"},"total_usd":0.263649,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"9-cis retinoic acid directly binds and activates RXRα, identifying it as the proximate endogenous ligand for this receptor via a nuclear receptor-dependent ligand trapping assay.\",\n      \"method\": \"Nuclear receptor-dependent ligand trapping assay, direct binding measurement\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct ligand binding demonstrated biochemically, foundational finding replicated across many subsequent studies\",\n      \"pmids\": [\"1309942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"RXRα functions as an obligatory heterodimerization partner for RAR, T3R, and VDR, co-purifying with these receptors and enabling their stable binding to DNA response elements organized as direct repeats.\",\n      \"method\": \"Extensive biochemical purification, co-purification, electrophoretic mobility shift assay (EMSA), functional transactivation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted heterodimerization biochemically with multiple receptors, replicated widely\",\n      \"pmids\": [\"1314167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Targeted loss-of-function mutation of RXRα in mice causes embryonic lethality with hypoplastic ventricular chamber development, establishing RXRα as a genetic component of the vitamin A signaling pathway in cardiac morphogenesis.\",\n      \"method\": \"Gene targeting (knockout mouse), histological and morphological analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined developmental phenotype, replicated and extended in subsequent studies\",\n      \"pmids\": [\"7926783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"RXRα binds to a retinoic acid response element within the hepatitis B virus enhancer in vitro, and transactivates an HBV enhancer-reporter construct in vivo upon retinoic acid treatment when co-transfected with RXRα; a single-base mutation in the response element abolishes both binding and enhancer activity.\",\n      \"method\": \"In vitro binding assay, in vivo reporter gene assay, site-directed mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct binding plus mutagenesis plus functional reporter assay in single study\",\n      \"pmids\": [\"1329088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"RXRα-null mice exhibit complex cardiac defects including ventricular septal, atrioventricular cushion, and conotruncal ridge defects; RXRα heterozygous embryos show an intermediate phenotype, demonstrating a gene dosage effect for RXRα in cardiac morphogenesis.\",\n      \"method\": \"Microdissection, scanning electron microscopy, genetic analysis of RXRα-/- and +/- embryos\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO/heterozygous analysis with defined phenotype, quantitative gene-dosage effect demonstrated\",\n      \"pmids\": [\"8823298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"RXRα functions non-cell-autonomously in cardiac morphogenesis: chimera analysis shows that RXRα-deficient cardiomyocytes develop normally when surrounded by wild-type cells, indicating RXRα acts in a non-myocyte lineage to induce cardiomyocyte proliferation; RXRα and N-myc regulate convergent but non-epistatic pathways.\",\n      \"method\": \"Chimera analysis with RXRα-/- ES cells, genetic epistasis analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous chimera analysis with multiple controls establishing non-cell-autonomous mechanism\",\n      \"pmids\": [\"9550727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Cre-mediated ablation of RXRα in epidermal keratinocytes causes progressive alopecia and epidermal hyperplasia, demonstrating that RXRα plays a key role in anagen initiation during hair follicle cycling; RXRα/VDR heterodimers are implicated as a major regulatory complex in hair cycling.\",\n      \"method\": \"Conditional knockout (Cre-loxP in keratinocytes), histological analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO with defined phenotypic readout, genetic evidence for VDR heterodimer involvement\",\n      \"pmids\": [\"11171393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PPARγ/RXRα heterodimers are functional transcriptional units in human cytotrophoblast differentiation; specific ligands for both receptors additively stimulate human CG secretion, and RXRα and PPARγ proteins from cytotrophoblast nuclear extracts bind to the human CG β5 gene regulatory region.\",\n      \"method\": \"Transient transfection/reporter assay, nuclear extract DNA binding, hormone secretion assays, in vitro cytotrophoblast differentiation\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (binding, reporter, hormone secretion) in single study\",\n      \"pmids\": [\"11564716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PPARγ/RXRα heterodimers inhibit human extravillous cytotrophoblast invasion in vitro; PPARγ agonists synergize with RXR agonists, and a pan-RXR antagonist reverses PPARγ agonist-induced inhibition, placing RXRα as a required partner in this pathway.\",\n      \"method\": \"Primary extravillous cytotrophoblast invasion assay, pharmacological agonist/antagonist treatment\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional invasion assay with reciprocal pharmacological manipulation, single lab\",\n      \"pmids\": [\"11600579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hepatocyte RXRα deficiency prevents TCPOBOP-induced hepatomegaly and abolishes induction of CYP2A5, CYP2B10, and CYP3A1 (but not CYP2E1 or CYP2D6), establishing RXRα as an essential in vivo partner for CAR- and PXR-mediated xenobiotic metabolism.\",\n      \"method\": \"Hepatocyte-specific RXRα knockout mice challenged with CAR/PXR ligands, Northern blotting, morphological analysis\",\n      \"journal\": \"European journal of pharmaceutical sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean tissue-specific KO with defined gene expression phenotype, multiple ligands tested\",\n      \"pmids\": [\"11803135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Obstructive cholestasis reduces hepatic RAR α:RXRα nuclear protein levels and their binding to the Mrp2 promoter, with IL-1β treatment of primary hepatocytes reducing both Mrp2 and RXRα expression; renal RAR α:RXRα and Mrp2 are preserved, establishing organ-specific cytokine-dependent regulation of RXRα abundance as a mechanism for Mrp2 downregulation.\",\n      \"method\": \"Bile duct ligation model, EMSA, immunoblotting, ribonuclease protection assay, primary hepatocyte treatment\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple methods (EMSA, protein, RNA) in vivo and in vitro, organ-specific comparison\",\n      \"pmids\": [\"12145812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Docosahexaenoic acid (DHA, an n-3 PUFA) dose-dependently activates RXRα in colonocytes using a mammalian one-hybrid assay; this activation is abolished by an RXRα antagonist but not a PPARγ antagonist, identifying DHA as a specific RXRα ligand in colonocytes.\",\n      \"method\": \"Mammalian one-hybrid assay, reporter gene assay with RXRα antagonist\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional receptor activation assay with pharmacological controls, single lab\",\n      \"pmids\": [\"12844485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Sulindac and its analog K-80003 bind to RXRα and inhibit an N-terminally truncated form (tRXRα) that interacts with p85α subunit of PI3K; TNFα promotes tRXRα/p85α interaction to activate PI3K/AKT signaling, and sulindac inhibits this interaction leading to activation of death receptor-mediated apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, drug binding assay, AKT activation assay, cell apoptosis assay, animal tumor model\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, analog with improved RXRα affinity but no COX activity, in vivo tumor model, multiple orthogonal methods\",\n      \"pmids\": [\"20541701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Magnolol acts as a dual agonist for both RXRα and PPARγ; co-crystal structures of magnolol bound to RXRα and PPARγ LBDs reveal magnolol occupies the L-shaped ligand-binding pocket of RXRα with two hydroxyphenyl moieties in acidic and hydrophobic cavities; magnolol shows biased agonism on PPRE-mediated (RXRα:PPARγ heterodimer) transcription over RXRE-mediated (RXRα homodimer) transcription.\",\n      \"method\": \"Co-crystal structure (X-ray crystallography), transactivation assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures of both receptor LBDs with ligand plus functional transactivation assays, single lab\",\n      \"pmids\": [\"22140563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Crystal structure of the PXR/RXRα ligand-binding domain heterotetramer at 2.8 Å resolution reveals an unprecedented heterotetramer arrangement; both PXR and RXRα bind SRC-1 coregulator with higher affinity as part of this complex than as monomers; full-length receptors show defined binding preferences for direct and everted repeat DNA elements.\",\n      \"method\": \"X-ray crystallography, coregulator binding assay, recombinant full-length receptor DNA binding assay\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus functional coregulator binding assay plus DNA binding characterization\",\n      \"pmids\": [\"23602807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Crystal structure of the RXRα-LXRβ heterodimer on its cognate AGGTCA DR4 element reveals an extended X-shaped arrangement with crossed DNA- and ligand-binding domains, contrasting with the parallel domain arrangement of NRs on DR1 elements; LXRβ uses auxiliary DNA contacts and RXRα adapts flexibly to the heterodimeric complex.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with direct structural comparison to other NR complexes\",\n      \"pmids\": [\"24561505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sulindac analogs K-8008 and K-8012 bind to a novel site on the RXRα LBD (distinct from the classical ligand-binding pocket) in tetrameric RXRα, inhibit tRXRα/p85α interaction, suppress AKT activation and induce apoptosis; crystal structures define this non-canonical binding mechanism.\",\n      \"method\": \"X-ray crystallography, Co-IP, AKT activation assay, apoptosis assay\",\n      \"journal\": \"Chemistry & biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus functional assays confirming binding at novel site\",\n      \"pmids\": [\"24704507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Nitrostyrene derivatives bind to RXRα through the nitro group interacting with Cys432, activating Gal4-DBD-RXRα-LBD transactivation; they inhibit tRXRα interaction with TRAF2, reduce TNFα-induced ubiquitination of RIP1, and potently inhibit TNFα/NF-κB signaling in a tRXRα-dependent manner.\",\n      \"method\": \"Ligand binding assay, site-directed mutagenesis (Cys432 substitution), transactivation assay, Co-IP, ubiquitination assay, NF-κB reporter assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis identifying Cys432, functional assays with multiple orthogonal readouts\",\n      \"pmids\": [\"25795708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Crystal structure of multi-domain RARβ-RXRα heterodimer bound to DNA, ligands, and coactivator peptides reveals that RARβ LBD and DBD are physically connected to foster allosteric signal transmission; RXRα maintains flexible loosely organized domains, while heterodimerization partners use their LBD surface to form domain-domain interactions with DBDs.\",\n      \"method\": \"X-ray crystallography, hydrogen-deuterium exchange mass spectrometry, mutagenesis, functional assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multi-domain crystal structure plus HDX-MS plus mutagenesis plus functional studies in one study\",\n      \"pmids\": [\"29021580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Recurrent RXRA S427F/Y mutations in bladder cancer allosterically activate the PPARγ/RXRα heterodimer; structure-function studies show the substitution allosterically regulates the PPAR AF2 domain via an aromatic interaction with the terminal tyrosine in PPARs; mutant RXRA drives growth-factor-independent urothelial proliferation reversible by PPAR inhibition.\",\n      \"method\": \"Structure-function mutagenesis, enhancer/promoter reporter assays, bladder organoid growth assay, PPAR inhibitor treatment\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mechanistic structure-function study with organoid functional validation and pharmacological rescue\",\n      \"pmids\": [\"29143738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Berberine directly binds RXRα at a unique region (residues Gln275, Arg316, Arg371) distinct from the classical 9-cis-RA binding pocket, promoting RXRα interaction with nuclear β-catenin and leading to c-Cbl-mediated degradation of β-catenin; berberine suppresses colon xenograft growth in an RXRα-dependent manner.\",\n      \"method\": \"Direct binding assay, site-directed mutagenesis, Co-IP, protein degradation assay, xenograft model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — identified binding residues by mutagenesis, confirmed with Co-IP and in vivo RXRα-dependent tumor suppression\",\n      \"pmids\": [\"28846104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"FXR/RXRα LBD heterodimer crystal structures show that both FXR and RXRα bind SRC-1 coregulator with higher affinity in the heterodimer than as monomers; heterodimerization and ligand binding induce conformational changes in FXR helix 11 C-terminus affecting coactivator binding surface stability.\",\n      \"method\": \"X-ray crystallography, coregulator binding affinity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus quantitative coregulator binding assay\",\n      \"pmids\": [\"30275017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RXRα is phosphorylated at its N-terminal A/B domain by Cdk1 at the onset of mitosis, triggering its translocation to the centrosome where phosphorylated RXRα (p-RXRα) interacts with PLK1 through its N-terminal A/B domain to promote PLK1 activation, centrosome maturation, and mitotic progression.\",\n      \"method\": \"Live cell imaging, subcellular fractionation, Co-IP, phosphorylation assays, Cdk1 activity assay, kinase inhibitor studies\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — identified phosphorylation site (Cdk1), direct interaction with PLK1, localization with functional consequence, replicated in cancer cells and animal models\",\n      \"pmids\": [\"33321102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"lncRNA DANCR binds RXRA and increases its serine 49/78 phosphorylation via GSK3β, resulting in activation of PIK3CA transcription and enhanced PI3K/AKT signaling in triple-negative breast cancer.\",\n      \"method\": \"RNA-protein binding assay, phosphorylation assay, reporter assay, knockdown/overexpression in vitro and in vivo\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, identified phosphorylation sites and kinase, functional knockdown confirmed, but mechanism somewhat indirect\",\n      \"pmids\": [\"30518934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RXRA knockdown in senescent cells induces ITPR2-MCU calcium signaling, leading to ROS production, DNA damage, and p53-dependent cellular senescence; RXRA overexpression decreases DNA damage and delays replicative senescence.\",\n      \"method\": \"siRNA screen, knockdown/overexpression, calcium signaling measurement, ROS assay, DNA damage markers\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA screen identified RXRA, functional validation with KD and OE, mechanistic pathway placed via ITPR2-MCU axis, single lab\",\n      \"pmids\": [\"30216632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Truncated RXRα (tRXRα) expressed in myeloid cells interacts extensively with TRAF6 in the cytoplasm of macrophages, leading to TRAF6 ubiquitination and NF-κB activation, which induces IL-6 secretion and STAT3 activation to promote colitis-associated colorectal tumorigenesis.\",\n      \"method\": \"Transgenic mouse model, Co-IP, ubiquitination assay, cytokine measurement, NF-κB reporter assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic in vivo model plus mechanistic Co-IP and ubiquitination assays identifying TRAF6 interaction\",\n      \"pmids\": [\"30931933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Qki serves as a coactivator of the PPARβ-RXRα complex in oligodendrocytes, controlling transcription of lipid metabolism genes (especially fatty acid desaturation and elongation) required for mature myelin lipid maintenance; Qki depletion causes rapid demyelination rescuable by PPARβ/RXR agonists.\",\n      \"method\": \"Oligodendrocyte-specific Qki knockout, Co-IP, transcriptome analysis, pharmacological rescue with PPARβ/RXR agonists, high-fat diet rescue\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO, coactivator interaction by Co-IP, pharmacological and dietary rescue, human disease correlation\",\n      \"pmids\": [\"32202512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RXRα agonist SR11237 destabilizes the RXRα homodimer but promotes PPARγ:RXRα heterodimer formation; incorporation of PPARγ into the heterodimer results in substantial gain in coactivator CBP-1 affinity even without ligands, and SR11237 indirectly promotes coactivator binding to PPARγ by shifting RXRα oligomerization preference.\",\n      \"method\": \"FRET-based coactivator recruitment assay, RXRα LBD mutagenesis (coactivator-binding-deficient mutant), heterodimer formation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis separating coactivator binding from dimerization, quantitative FRET assays demonstrating allosteric mechanism\",\n      \"pmids\": [\"34081964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"JNK2α phosphorylates RXRα at Ser260 in vivo; hepatocyte-specific expression of phosphorylation-site mutant RXRα demonstrates that Ser260 phosphorylation is required for JNK2α-mediated suppression of FGF21 gene expression and metabolic dysregulation.\",\n      \"method\": \"Quantitative phosphoproteomics, hepatocyte-specific knock-in of wild-type vs. mutant RXRα (Ser260 site), Fgf21 expression measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — phosphoproteomic identification of site, genetic validation using site-specific mutant knock-in mice\",\n      \"pmids\": [\"36282921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"RXRα ligands activate Nurr1-RXRα transcription through a mechanism involving weakening of the Nurr1-RXRα LBD heterodimer affinity and heterodimer dissociation (PPI inhibition), releasing a transcriptionally active Nurr1 monomer from a repressive complex; this is distinct from classical agonist mechanisms and correlates with RXRα homodimer antagonism rather than agonism.\",\n      \"method\": \"NMR spectroscopy, protein-protein interaction assay, cellular transcription assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR structural data plus PPI assay plus cellular transcription assay, mechanistic paradigm established with multiple orthogonal methods\",\n      \"pmids\": [\"37102494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Dexamethasone increases RXRα mRNA and protein expression in primary rat hepatocytes, and adenoviral overexpression of RXRα enhances T3-dependent type I 5'-deiodinase mRNA induction, demonstrating that glucocorticoid-induced RXRα upregulation augments thyroid hormone receptor signaling by increasing the availability of this obligatory heterodimerization partner.\",\n      \"method\": \"Northern blot, Western blot, EMSA, adenoviral overexpression, primary hepatocyte culture\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple methods (RNA, protein, EMSA, gain-of-function) demonstrating mechanism, multiple T3-target genes tested\",\n      \"pmids\": [\"9924183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"RXRα down-regulation is required for neutrophil differentiation from granulocyte/monocyte progenitors; ectopic RXRα expression inhibits granulopoiesis and redirects G-CSF-dependent granulocyte differentiation to the monocyte lineage; dominant-negative RXRα promotes late-stage granulocyte generation in vitro and in vivo.\",\n      \"method\": \"Ectopic RXRα overexpression, dominant-negative RXRα, human in vitro myeloid cultures, in vivo reconstituted mouse model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain and loss of function in both in vitro and in vivo models, lineage fate switching as phenotypic readout\",\n      \"pmids\": [\"17018855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PRKAR1A-RARα leukemic transformation critically depends on RXRα interaction: point mutations eliminating RXRα interaction with the RARα portion of the fusion protein, shRNA knockdown of RXRα, or RXRα agonist treatment all reduce transformation capability in murine bone marrow retroviral transduction assay.\",\n      \"method\": \"Bone marrow retroviral transduction/transformation assay, gel-shift assay, point mutagenesis, shRNA knockdown\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (mutagenesis, shRNA, pharmacology) all converging on RXRα requirement for transformation\",\n      \"pmids\": [\"19965660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Retinol treatment increases RXRα-β-catenin protein interaction and triggers relocation of both proteins to the cytosol; RXRα lacking the AF-1 and DNA-binding domains abolishes β-catenin co-purification and proteasomal degradation of β-catenin, establishing that RXRα/β-catenin binding is required for proteasomal degradation of β-catenin.\",\n      \"method\": \"Co-immunoprecipitation, domain deletion mutant transfection, proteasome inhibitor treatment, subcellular fractionation\",\n      \"journal\": \"Nutrition and cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus domain deletion mutant establishing structural requirement, single lab\",\n      \"pmids\": [\"18444141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PPARα/RXRα complex promotes proteasomal degradation of HNF4α in the presence of RXRα, downregulating amino acid catabolism genes in the liver; chromatin immunoprecipitation shows HNF4α binds the SDS promoter, and RXRα presence is essential for PPARα-mediated repression of this activity.\",\n      \"method\": \"PPARα knockout mouse model, chromatin immunoprecipitation, protein degradation assay, gene expression analysis\",\n      \"journal\": \"Metabolism: clinical and experimental\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse plus ChIP plus degradation assay, single lab\",\n      \"pmids\": [\"33422545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SILENCING RXRA in A431 squamous carcinoma cells only partially reduces 1,25(OH)2D3-induced differentially expressed genes at 24 h (unlike VDR knockout which abolishes the response), and classic 1,25(OH)2D3 targets CYP24A1 and CAMP are regulated in an RXRA-independent manner, demonstrating that a subset of VDR genomic actions do not require RXRA.\",\n      \"method\": \"RXRA gene silencing/knockout, transcriptome analysis, immunofluorescence co-localization\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with genome-wide transcriptome readout, but negative/partial finding with RXRA\",\n      \"pmids\": [\"38123121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RXRA directly activates the PLD1 promoter in cervical cancer cells; LINC00511 binds RXRA (demonstrated by RNA immunoprecipitation) and recruits it to the PLD1 promoter (shown by chromatin immunoprecipitation), upregulating PLD1 expression to promote cervical cancer cell proliferation.\",\n      \"method\": \"RNA immunoprecipitation, chromatin immunoprecipitation, dual-luciferase reporter assay, siRNA knockdown\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal RNA-IP and ChIP plus reporter assay, single lab\",\n      \"pmids\": [\"32067228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TET1-mediated DNA demethylation at the Rxra locus promotes RXRα expression during adipogenesis; Tet1 knockout decreases 5hmC at Rxra, reduces RXRα expression, and impairs adipocyte differentiation; RXRα agonist partially rescues the Tet1 KO adipogenesis defect.\",\n      \"method\": \"TET1 knockout, 5mC/5hmC DNA immunoprecipitation, RNA-seq, RXRα agonist rescue\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with epigenomic readout and pharmacological rescue, single lab\",\n      \"pmids\": [\"33684567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Qki acts as coactivator of PPARβ-RXRα: Qki depletion in oligodendrocytes specifically reduces myelin lipid (monounsaturated and very-long-chain fatty acids) without affecting myelin proteins, and neurological deficits are alleviated by high-fat diet or PPARβ/RXR agonist treatment.\",\n      \"method\": \"Oligodendrocyte-specific Qki KO, lipidomics, PPARβ/RXR agonist treatment, high-fat diet rescue\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO with lipidomics, coactivator interaction by Co-IP, multiple rescue approaches, human MS correlation\",\n      \"pmids\": [\"32202512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RXRα down-regulation in senescent macrophages mediates elevated COX2 expression and PGE2 production via increased NF-κB activity; systemic treatment of young mice with RXRα antagonist HX531 increases COX2, TNF-α, and IL-6 expression in splenocytes, establishing RXRα as a suppressor of NF-κB-driven inflammation in macrophages.\",\n      \"method\": \"Macrophage senescence model, COX2/PGE2 measurement, RXRα knockdown/antagonist treatment in vivo and in vitro\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — functional assays with pharmacological tools plus in vivo antagonist, mechanistic pathway placed, single lab\",\n      \"pmids\": [\"24051096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FABP7 promotes glioblastoma stem cell migration through nuclear delivery of polyunsaturated fatty acids (PUFAs) to RXRα; FABP7-mediated activation of RXRα upregulates SOX2 and ZEB1 (demonstrated by gel shift and luciferase reporter assays), driving a stationary-to-migratory transition in GSCs.\",\n      \"method\": \"Gel shift assay, luciferase reporter assay, xenograft migration model, single-cell RNA sequencing\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gel shift and reporter assays establishing FABP7→RXRα→SOX2/ZEB1 pathway, in vivo xenograft validation, single lab\",\n      \"pmids\": [\"37499046\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RXRα is a nuclear receptor that functions primarily as an obligatory heterodimerization partner for numerous other nuclear receptors (RAR, T3R, VDR, PPAR, LXR, FXR, PXR, CAR, Nurr1, and others), binding to direct-repeat DNA response elements to regulate transcription; its canonical ligand is 9-cis retinoic acid, but it can also be activated by DHA and other ligands at its classical LBD pocket or by small molecules at novel surface sites; in addition to its nuclear transcriptional role, RXRα is proteolytically truncated to generate tRXRα in tumors, which interacts with PI3K/p85α and TRAF6 in the cytoplasm to activate AKT and NF-κB signaling; at mitosis onset, Cdk1 phosphorylates RXRα at its N-terminal A/B domain, causing centrosomal translocation where it activates PLK1 to promote mitotic progression; JNK2α phosphorylates RXRα at Ser260 to suppress hepatic FGF21 expression; and RXRα is essential in vivo for cardiac morphogenesis (non-cell-autonomously), skin keratinocyte homeostasis, xenobiotic metabolism via CAR/PXR, neutrophil differentiation, and myelin lipid maintenance via PPARβ-RXRα coactivation by Qki.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RXRα is a nuclear receptor that operates as the obligatory heterodimerization partner for a broad array of nuclear receptors—RAR, T3R, VDR, PXR, CAR, PPARγ, PPARβ, PPARα, LXRβ, FXR, and Nurr1—enabling their stable binding to direct-repeat DNA response elements and ligand-dependent transcriptional control [#1, #9, #14, #15, #18, #21]. Its proximate endogenous ligand is 9-cis retinoic acid [#0], and it is additionally activated by docosahexaenoic acid and a chemically diverse set of small molecules that bind either the classical L-shaped ligand pocket or non-canonical surface sites including Cys432 and an alternate region centered on Gln275/Arg316/Arg371 [#11, #13, #16, #17, #20]. Within heterodimers RXRα acts as an allosteric platform: its oligomerization state and ligand occupancy tune coactivator (SRC-1, CBP) recruitment to the partner receptor, and partner LBDs form domain–domain contacts that transmit allosteric signals across the complex [#14, #18, #21, #27]; ligand-driven dissociation of the Nurr1–RXRα heterodimer represents a distinct PPI-inhibition mode of transcriptional activation [#29]. Genetically, RXRα is essential in vivo for cardiac morphogenesis, where it acts non-cell-autonomously in a non-myocyte lineage to drive cardiomyocyte proliferation in a gene-dosage-dependent manner [#2, #4, #5], for keratinocyte and hair-follicle homeostasis via RXRα/VDR complexes [#6], for CAR/PXR-dependent hepatic xenobiotic metabolism [#9], for neutrophil-versus-monocyte lineage decisions [#31], and for PPARβ-RXRα-driven myelin lipid maintenance coactivated by Qki [#26, #38]. Beyond transcription, RXRα is subject to regulatory phosphorylation: Cdk1 phosphorylates its N-terminal A/B domain at mitotic onset, driving centrosomal translocation and PLK1 activation to promote mitotic progression [#22], and JNK2α phosphorylates Ser260 to suppress hepatic FGF21 expression [#28]. In tumors, an N-terminally truncated cytoplasmic form (tRXRα) interacts with the PI3K p85α subunit to activate AKT and with TRAF6 to drive NF-κB/IL-6/STAT3 signaling, linking RXRα to survival and inflammatory tumorigenesis; sulindac analogs and nitrostyrene derivatives that bind RXRα disrupt these interactions and restore apoptosis [#12, #16, #17, #25]. Recurrent RXRA S427F/Y mutations allosterically activate the PPARγ/RXRα heterodimer to drive growth-factor-independent urothelial proliferation [#19].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing RXRα's endogenous ligand and its core biochemical role answered what activates the receptor and how it engages DNA, defining it as a ligand-controlled heterodimeric transcription factor.\",\n      \"evidence\": \"Ligand trapping/direct binding for 9-cis-RA, plus biochemical co-purification and EMSA with RAR/T3R/VDR\",\n      \"pmids\": [\"1309942\", \"1314167\", \"1329088\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of physiological heterodimer partners not yet defined\", \"Structural basis of DNA-element selectivity not addressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Knockout and chimera studies answered whether RXRα is genetically required for development and where it acts, revealing an essential non-cell-autonomous role in cardiac morphogenesis with gene-dosage sensitivity.\",\n      \"evidence\": \"Conventional and heterozygous RXRα knockout mice plus RXRα-/- ES cell chimera analysis\",\n      \"pmids\": [\"7926783\", \"8823298\", \"9550727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the non-myocyte signal induced by RXRα not defined\", \"Downstream transcriptional targets in the responsible lineage unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Tissue-specific knockouts answered which physiological partner-receptor programs depend on RXRα in vivo, establishing it as the required dimer partner for VDR (hair cycling), CAR/PXR (xenobiotic metabolism), and PPARγ pathways.\",\n      \"evidence\": \"Keratinocyte- and hepatocyte-specific RXRα knockouts; cytotrophoblast reporter and invasion assays\",\n      \"pmids\": [\"11171393\", \"11803135\", \"11564716\", \"11600579\", \"12145812\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RXRα ligand occupancy is required versus a permissive scaffold role not separated for each partner\", \"Mechanism of cytokine-driven RXRα downregulation in cholestasis incomplete\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Gain- and loss-of-function in myeloid cells answered whether RXRα levels instruct lineage choice, showing its down-regulation is required for neutrophil differentiation and its persistence redirects cells toward the monocyte lineage.\",\n      \"evidence\": \"Ectopic and dominant-negative RXRα in human myeloid cultures and reconstituted mouse models\",\n      \"pmids\": [\"17018855\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target genes mediating the lineage switch not defined\", \"Heterodimer partner responsible for the granulopoietic block unidentified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Ligand-activation assays answered whether RXRα senses dietary fatty acids, identifying DHA as a specific RXRα-activating ligand distinct from PPARγ activation.\",\n      \"evidence\": \"Mammalian one-hybrid and reporter assays with RXRα versus PPARγ antagonists in colonocytes\",\n      \"pmids\": [\"12844485\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding affinity of DHA for RXRα not measured\", \"Physiological relevance of DHA-RXRα signaling in vivo not established\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery of cytoplasmic truncated tRXRα answered how RXRα contributes to tumor survival outside transcription, linking it to PI3K/p85α-driven AKT signaling that is druggable by sulindac analogs.\",\n      \"evidence\": \"Reciprocal Co-IP, COX-inactive analog K-80003, AKT and apoptosis assays, tumor model\",\n      \"pmids\": [\"20541701\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protease generating tRXRα not identified\", \"Determinants of cytoplasmic versus nuclear partitioning unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"A series of crystal structures answered how heterodimer architecture and ligand binding are coordinated, revealing partner-specific DNA-element geometries, allosteric domain coupling, and cooperative coregulator recruitment.\",\n      \"evidence\": \"X-ray structures of RXRα with PXR, LXRβ, FXR, RARβ, and PPARγ LBDs plus HDX-MS, coregulator binding, and DNA-binding assays\",\n      \"pmids\": [\"23602807\", \"24561505\", \"30275017\", \"29021580\", \"22140563\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length heterodimer-on-DNA conformational dynamics in solution not fully resolved\", \"How distinct response-element geometries map to in vivo target selection incomplete\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mapping non-canonical small-molecule binding sites answered how diverse compounds modulate RXRα beyond the classical pocket, defining Cys432 and an alternate Gln275/Arg316/Arg371 region as functional sites controlling tRXRα interactions and β-catenin degradation.\",\n      \"evidence\": \"Crystallography, site-directed mutagenesis, Co-IP, ubiquitination, NF-κB and xenograft assays for sulindac analogs, nitrostyrenes, and berberine\",\n      \"pmids\": [\"24704507\", \"25795708\", \"28846104\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous ligands for these surface sites unknown\", \"Selectivity of these compounds across nuclear receptors not fully characterized\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Characterizing recurrent RXRA S427F/Y mutations answered how RXRα itself can be an oncogenic driver, showing the substitution allosterically activates the PPARγ/RXRα heterodimer to drive ligand-independent urothelial proliferation.\",\n      \"evidence\": \"Structure-function mutagenesis, reporter assays, bladder organoid growth, and PPAR inhibitor rescue\",\n      \"pmids\": [\"29143738\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Frequency and tissue range of the activating mechanism beyond bladder not defined\", \"Whether the mutant alters other heterodimers not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Phosphorylation studies answered how kinase signaling repurposes RXRα, identifying Cdk1-driven centrosomal PLK1 activation in mitosis and JNK2α-Ser260 suppression of hepatic FGF21.\",\n      \"evidence\": \"Phosphoproteomics, Cdk1/JNK2α phosphorylation assays, PLK1 Co-IP, and Ser260 knock-in mice\",\n      \"pmids\": [\"33321102\", \"36282921\", \"30518934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between these phosphorylation events and transcriptional output not integrated\", \"Whether centrosomal RXRα requires its DNA-binding function unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Coactivator and metabolic studies answered how RXRα heterodimers control lipid programs, showing Qki coactivates PPARβ-RXRα to maintain myelin lipids and that allosteric heterodimer formation gains coactivator affinity even without ligand.\",\n      \"evidence\": \"Oligodendrocyte-specific Qki knockout with lipidomics and agonist rescue; FRET coactivator-recruitment and RXRα oligomerization assays\",\n      \"pmids\": [\"32202512\", \"34081964\", \"33684567\", \"33422545\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How RXRα oligomerization state is set in vivo not defined\", \"Generality of the ligand-independent coactivator gain across partners untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Newer mechanistic and disease-context studies answered how RXRα ligands act through dimer dissociation and how lipid carriers and lncRNAs route RXRα into cancer programs, expanding the activation paradigm beyond classical agonism.\",\n      \"evidence\": \"NMR and PPI assays for Nurr1-RXRα dissociation; FABP7 PUFA delivery, RNA-IP/ChIP for LINC00511 and DANCR, and senescence calcium-signaling assays\",\n      \"pmids\": [\"37102494\", \"37499046\", \"32067228\", \"30216632\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Several cancer-context mechanisms rest on single-lab data\", \"How dimer-dissociation activation generalizes to other RXRα partners unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how RXRα's nuclear transcriptional, cytoplasmic tRXRα, and centrosomal/phosphorylation-dependent functions are coordinately controlled within a single cell, and what governs the switch between heterodimer scaffold, allosteric coactivator platform, and non-genomic signaling roles.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking RXRα localization, proteolysis, and phosphorylation states\", \"Protease and trafficking determinants of tRXRα generation unidentified\", \"In vivo balance of ligand-dependent versus permissive heterodimer functions unquantified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 3, 7, 18, 19, 36, 40]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 3, 14, 15, 36]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 11, 13, 40]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 11, 13]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 3, 7, 30, 36]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [12, 25, 33]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 14, 18, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 4, 5, 6, 31]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [9, 26, 28, 34, 37, 38]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [12, 17, 25]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [12, 19, 25, 40]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"complexes\": [\n      \"RXRα/PPARγ heterodimer\",\n      \"RXRα/VDR heterodimer\",\n      \"RXRα/RAR heterodimer\",\n      \"PXR/RXRα LBD heterotetramer\"\n    ],\n    \"partners\": [\n      \"RARA\",\n      \"PPARG\",\n      \"VDR\",\n      \"PXR\",\n      \"LXRB\",\n      \"FXR\",\n      \"PLK1\",\n      \"TRAF6\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}